Skip to main content
Clinical Trials/NCT01925898
NCT01925898
Unknown
Phase 4

A Randomized, Clinical Trial of Oral Midazolam Versus Oral Ketamine for Sedation During Laceration Repair.

Assaf-Harofeh Medical Center1 site in 1 country60 target enrollmentAugust 2013

Overview

Phase
Phase 4
Intervention
Midazolam - active comparator
Conditions
Lacerations
Sponsor
Assaf-Harofeh Medical Center
Enrollment
60
Locations
1
Primary Endpoint
Pain score: Visual analog score (VAS)- by a parent
Last Updated
12 years ago

Overview

Brief Summary

Sedation is often needed for young children undergoing minor procedures in the emergency department (ED). Oral midazolam is one of the most commonly used regimens for children undergoing laceration repair but its sedative efficacy was shown to be suboptimal. In only one randomized controlled study oral ketamine has been used successfully for procedural sedation for laceration repair. A recent study showed that the combination of oral midazolam and oral ketamine provided deeper sedation compared with oral midazolam alone. However children treated wuth the combination of midazolam and ketamine required longer recovery

Hypothesis:

Oral ketamine can provide superior sedation to oral midazolam in children requiring sedation for laceration repair.

Registry
clinicaltrials.gov
Start Date
August 2013
End Date
July 2014
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Any child with laceration requiring sedation

Exclusion Criteria

  • Major trauma
  • Closed head injury associated with loss of consciousness
  • Abnormal neurologic examination in a previously normal child
  • Significant developmental delay or baseline neurological deficit
  • A patient with seizures
  • Elevated intra-cranial pressure
  • Hypersensitivity to midazolam or ketamine
  • Hypertension
  • Hyperthyroidism or a patient receiving thyroid replacement
  • alcohol intoxication or a history of alcohol abuse

Arms & Interventions

Midazolam

Oral Midazolam

Intervention: Midazolam - active comparator

Outcomes

Primary Outcomes

Pain score: Visual analog score (VAS)- by a parent

Time Frame: During the procedure - up to 1 hour

A parent will assess the child's pain on a Visual analog scale

Number of patients requiring IV sedation

Time Frame: During the procedure - up to 1 hour

patients who fail to achieve University of Michigan Sedation Scale (UMSS) of two or higher will be switched to IV sedation

Secondary Outcomes

  • • Patients and parents satisfaction assessed on VAS(While in the ED - estimated time around 2 hours)
  • UMSS - by ED physician(During the procedure - up to 1 hour)
  • • VAS by nurse(During the procedure - up to 1 hour)
  • Time to reach UMSS > 2(up to 1 hour)
  • • Procedure time(During the procedure - up to 1 hour)
  • • Time from procedure to full recovery(While in the ED - estimated time around 2 hours)
  • The occurrence of adverse effects during the ED stay(While in the ED - estimated time around 2 hours)

Study Sites (1)

Loading locations...

Similar Trials